stents

Dietas bajas en carbohidratos y progresión de la calcificación coronaria

Calcium Scoring: “Location” Seems to Be More Important than “Percentage”

The presence of a high percentage of calcium in the left main coronary artery is independently associated with a 20–30% greater risk for cardiovascular and all-cause death in asymptomatic adults. This highlights the fact that calcium location, and not only amount, is important. Calcium scoring reports from computerized tomography (CT) usually inform only that: how<a href="https://solaci.org/en/2019/07/18/calcium-scoring-location-seems-to-be-more-important-than-percentage/" title="Read more" >...</a>

Clinical Implications of the New Hypertension Guidelines

Hypertension is the first modifiable risk factor affecting morbidity and mortality in nearly half of the adults in the US. The new ACC/AHA guidelines have issued new standards for the detection assessment and management of high blood pressure. The major change compared against their prior version was stage 1 hypertension definition, defined as systolic blood<a href="https://solaci.org/en/2019/07/18/clinical-implications-of-the-new-hypertension-guidelines/" title="Read more" >...</a>

Congreso SOLACI-SBHCI 2019

SOLACI-SBHCI 2019 Congress | International Joint Sessions

Prestigious Scientific Societies from all over the world will attend the Congress to discuss the latest advances in interventional cardiology. Discover the International Joint Sessions 01/08 | Paulista Room | 8:30 – 10:00 | Portuguese Society of Cardiology (APIC) Symposium – Acute Coronary Syndrome 8:30 – 8:42 – PCI in NSTEMI ACS: how and when<a href="https://solaci.org/en/2019/07/17/solaci-sbhci-2019-congress-international-joint-sessions/" title="Read more" >...</a>

Infarto agudo de miocardio y lesiones de múltiples niveles

New Promising Alternatives for Mitral Regurgitation

PASCAL transcatheter valve repair system for mitral regurgitation has shown feasibility and safety to treat patients with grade 3+ or 4+, regardless etiology. Regurgitation grade was significantly reduced, and this was accompanied by clinical improvement in functional class, exercise capacity and quality of life. This study soon to be published in J Am Coll Cardiol<a href="https://solaci.org/en/2019/07/15/new-promising-alternatives-for-mitral-regurgitation/" title="Read more" >...</a>

TAVI en insuficiencia aórtica pura, nuevos dispositivos con nuevos resultados

The FDA Affirms Mortality Signs with Paclitaxel Based Devices

Evidently, we are still uncertain. The information goes both ways, even on our own web page, we have been coming and going just like any other publication around the world. After a 2-day debate, the Circulatory System Devices FDA panel has confirmed the tendency to higher mortality with paclitaxel-based devices and is expected to debate<a href="https://solaci.org/en/2019/06/19/the-fda-affirms-mortality-signs-with-paclitaxel-based-devices/" title="Read more" >...</a>

SOLACI in Support of the Stent — Save a Life! Initiative

The Latin American Society of Interventional Cardiology has signed a cooperation agreement with the Stent — Save a Life! Initiative, a project created by the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and PCR in 2009. Its aim is to reduce morbidity and mortality in patients with acute coronary syndromes worldwide. The mission of this<a href="https://solaci.org/en/2019/06/07/solaci-in-support-of-the-stent-save-a-life-initiative/" title="Read more" >...</a>

Lo más leído de mayo en solaci.org

The Most Read Articles of may in Interventional Cardiology

1- Surprising EXCEL Outcomes in Diabetics with Main Left Stenosis This study especially designed to compare PCI vs. CABG in patients with left main coronary artery disease and low to intermediate Syntax score showed that 30-day and 3 -year outcomes of PCI with everolimus eluting stents vs CABG were consistent both in diabetic and non-diabetic<a href="https://solaci.org/en/2019/06/06/the-most-read-articles-of-may-in-interventional-cardiology/" title="Read more" >...</a>

Efecto a largo plazo de los balones liberadores con bajas dosis de paclitaxel

Mortality and Paclitaxel Devices, Data Are Aligning

5 years ago, several prospective randomized studies confirmed paclitaxel coated balloons were safe and effective in femoropopliteal territory. However, a recently published meta-analysis of heterogeneous studies including both paclitaxel coated balloons and drug eluting stents has linked these devices to mortality. In addition, higher doses were associated to higher mortality, both at 2 and 5<a href="https://solaci.org/en/2019/06/05/mortality-and-paclitaxel-devices-data-are-aligning/" title="Read more" >...</a>

EuroPCR 2019 | CHOICE: válvula balón expandible vs autoexpandibles en pacientes de alto riesgo

EuroPCR 2019 | MeRes-1: Bioresorbable Scaffolds Return with Renewed Strength

A small number of highly selected patients presents good outcomes with new bioresorbable scaffold MeRes, but much more evidence is necessary to bring back the concept. The MeRes-1 study tested the newest generation of the Meril Life Sciences bioresorbable scaffold, a device featuring thinner struts compared with Absorb (from 150 µm in Absorb to only<a href="https://solaci.org/en/2019/05/30/europcr-2019-meres-1-bioresorbable-scaffolds-return-with-renewed-strength/" title="Read more" >...</a>

EuroPCR 2019 | Stent Firehawk continúa con sus buenos resultados a 2 años frente al Xience

EuroPCR 2019 | Stent Firehawk Continues to Show Good Results at 2 Years vs. Xience

This device, an abluminal groove-filled biodegradable-polymer sirolimus-eluting stent manufactured in China, showed very similar efficacy and safety to the “gold standard” everolimus eluting Xience at 2-year follow up, according to the TARGET outcomes, presented yesterday at the EuroPCR 2019 and simultaneously published in J Am Coll Cardiol Intv. The device, which is manufactured in China<a href="https://solaci.org/en/2019/05/27/europcr-2019-stent-firehawk-continues-to-show-good-results-at-2-years-vs-xience/" title="Read more" >...</a>

Top